Breaking News Instant updates and real-time market news.

XLK

Technology Select Sector SPDR

$71.40 /

-3.315 (-4.44%)

08:24
03/23/20
03/23
08:24
03/23/20
08:24

Technology Select Sector SPDR: Pivot points

The following are the pivot points for the Technology Select Sector SPDR (XLK). Pivot High: $73.844, Pivot Low: $68.014. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

TODAY'S FREE FLY STORIES

Conference/Events
Sanderson Farms to host conference call » 16:21
03/28/20
03/28
16:21
03/28/20
16:21
SAFM

Sanderson Farms

$119.18 /

-5.08 (-4.09%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
GM agrees to $120M settlement to resolve ignition lawsuits, Bloomberg says » 12:42
03/28/20
03/28
12:42
03/28/20
12:42
GM

General Motors

$21.37 /

-1.17 (-5.19%)

General Motors agreed to…

General Motors agreed to a $120M settlement over faulty ignition switches that allegedly caused cars to stall and air bags to deploy, in some cases triggering fatal accidents, Bloomberg's Robert Burnson reports. The deal, which must be approved by a judge, would resolve hundreds of lawsuits filed before the automaker sought bankruptcy protection in 2009, the author notes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
SoftBank's OneWeb files for bankruptcy, Bloomberg reports » 12:40
03/28/20
03/28
12:40
03/28/20
12:40
SFTBY

SoftBank

$0.00 /

+ (+0.00%)

OneWeb filed for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Ocado buys 100,000 coronavirus testing kits from staff, Telegraph says » 10:59
03/28/20
03/28
10:59
03/28/20
10:59
OCDGF

Ocado Group

$0.00 /

+ (+0.00%)

Ocado has bought 100,000…

Ocado has bought 100,000 coronavirus testing kits to keep as many employees as possible in warehouses and on the road delivering food, The Telegraph's Phoebe Southworth, Tony Diver, Charles Hymas and Jack Hardy report. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Amgen announces results from Phase 3B study of Repatha » 10:17
03/28/20
03/28
10:17
03/28/20
10:17
AMGN

Amgen

$198.49 /

+ (+0.00%)

Amgen announced positive…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Edwards Lifesciences pauses enrollments in pivotal Mitral, Tricuspid trials » 10:14
03/28/20
03/28
10:14
03/28/20
10:14
EW

Edwards Lifesciences

$198.40 /

-1.49 (-0.75%)

Edwards Lifesciences…

Edwards Lifesciences announced it will temporarily pause new enrollments in its active pivotal clinical trials of transcatheter mitral and tricuspid therapies, in response to the urgent COVID-19 response around the globe. Edwards is coordinating with the trials' clinical investigators, and the decision to resume enrollments in the trials will be made in consultation with each investigator and hospital at the time when their clinicians' and patients' needs can be better served.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Merck presents results from VICTORIA trial evaluating vericiguat » 10:11
03/28/20
03/28
10:11
03/28/20
10:11
MRK

Merck

$71.62 /

-1.77 (-2.41%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

Merck (MRK) announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
AstraZeneca presents new data from sub-analysis of Phase III DAPA-HF trial » 10:08
03/28/20
03/28
10:08
03/28/20
10:08
AZN

AstraZeneca

$42.56 /

+0.26 (+0.61%)

New data from a…

New data from a sub-analysis of the landmark Phase III DAPA-HF trial showed that AstraZeneca's FARXIGA reduced the incidence of the primary composite endpoint of heart failure worsening or cardiovascular death compared to placebo, in patients with heart failure with reduced ejection fraction, irrespective of their background therapy. FARXIGA was evaluated in patients who were receiving a broad range of pharmacological treatments, device therapies and cardiac resynchronization therapy for HFrEF. A consistent reduction in the primary outcome was observed across all these treatment subgroups. FARXIGA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2D. In the US it is also approved to reduce the risk of hospitalization for HF in patients with T2D and established CV disease or multiple CV risk factors. In January 2020, the Food and Drug Administration accepted a supplemental New Drug Application and granted Priority Review for FARXIGA to reduce the risk of CV death or the worsening of HF in adults with HFrEF with and without T2D. The Prescription Drug User Fee Act date, the FDA action date for this supplemental application, is scheduled for the second quarter of 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Esperion announces data presentations of NEXLETOL, NEXLIZET Tablet » 09:56
03/28/20
03/28
09:56
03/28/20
09:56
ESPR

Esperion

$35.28 /

-2.07 (-5.54%)

Esperion announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Orica upgraded to Buy from Sell at Goldman Sachs » 09:51
03/28/20
03/28
09:51
03/28/20
09:51
OCLDY

Orica

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Alex Karpos double upgraded Orica to Buy from Sell with a A$20.10 price target. The analyst is more positive on mine production versus "capex-tied earnings" in the current environment and views the recent selloff in the stock as an attractive entry point.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Goldman adds Austal to ANZ Conviction List with 31% potential upside » 09:48
03/28/20
03/28
09:48
03/28/20
09:48
AUTLF

Austal

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Redwood Trust delays payment for previously declared 32c dividend » 08:03
03/28/20
03/28
08:03
03/28/20
08:03
RWT

Redwood Trust

$6.22 /

+0.05 (+0.81%)

Redwood Trust announced…

Redwood Trust announced that it has delayed the payment date for its previously declared 32c per share common stock dividend for the first quarter of 2020. The first quarter 2020 dividend is now scheduled to be paid on June 12, 2020. As previously announced on February 27, 2020, the first quarter 2020 dividend will continue to be payable to stockholders of record on March 16, 2020. Christopher Abate, Chief Executive Officer of Redwood Trust, explained, "We remain focused on paying the first quarter dividend. While the decision to delay the payment of this dividend was difficult to make, we believe it is in the best interests of Redwood during this period of near-term uncertainty and volatility caused by the COVID-19 pandemic."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Merck, Intel among stocks multifactor-screened for extra safety, Barron's says » 07:23
03/28/20
03/28
07:23
03/28/20
07:23
CAT

Caterpillar

$105.20 /

-5.49 (-4.96%)

, MRK

Merck

$71.62 /

-1.77 (-2.41%)

, UNH

UnitedHealth

$241.80 /

-12.62 (-4.96%)

, INTC

Intel

$52.35 /

-3.26 (-5.86%)

, HON

Honeywell

$131.13 /

-6.095 (-4.44%)

, BBY

Best Buy

$62.36 /

-0.69 (-1.09%)

, GWW

Grainger

$246.57 /

+1.17 (+0.48%)

, DHI

D.R. Horton

$36.79 /

-2.58 (-6.55%)

, QCOM

Qualcomm

$66.50 /

-2.48 (-3.60%)

, AKAM

Akamai

$90.45 /

-4.05 (-4.29%)

, LMT

Lockheed Martin

$348.48 /

-1.96 (-0.56%)

, BLK

BlackRock

$434.59 /

-17.24 (-3.82%)

The financial markets are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Still value in Softbank stock, Barron's says » 07:07
03/28/20
03/28
07:07
03/28/20
07:07
SFTBY

SoftBank

$0.00 /

+ (+0.00%)

The coronavirus pandemic…

The coronavirus pandemic has further complicated matters for Softbank, pushing its market cap 70% below its asset value, and the company announced a plan to sell $41B of assets over the next 12 months and use $18B of the proceeds to buy back stock, on top of its existing $4.8B buyback, Eric Savitz writes in this week's edition of Barron's. At $35, Softbank's stock still sits at a 66% discount to its assets, the author notes, adding that the company has holdings worth almost triple its current stock price. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Apple, Amazon to come out of downturn strong, Barron's says » 07:02
03/28/20
03/28
07:02
03/28/20
07:02
GOOG

Alphabet

$1,110.80 /

-50.63 (-4.36%)

, GOOGL

Alphabet Class A

$1,109.46 /

-53.25 (-4.58%)

, AMZN

Amazon.com

$1,900.79 /

-52.4 (-2.68%)

, AAPL

Apple

$247.74 /

-10.74 (-4.16%)

, MSFT

Microsoft

$149.66 /

-6.35 (-4.07%)

Microsoft (MSFT), Apple…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Week in Review: How Trump's policies moved stocks » 06:30
03/28/20
03/28
06:30
03/28/20
06:30
GM

General Motors

$21.37 /

-1.17 (-5.19%)

, F

Ford

$5.19 /

-0.07 (-1.33%)

, AAPL

Apple

$247.74 /

-10.74 (-4.16%)

, ADM

Archer Daniels

$33.52 /

-0.975 (-2.83%)

, GPP

Green Plains Partners

$7.10 /

+1.7 (+31.48%)

, BG

Bunge

$36.21 /

-1.59 (-4.21%)

, PEIX

Pacific Ethanol

$0.28 /

-0.0728 (-20.63%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Morgan Stanley wins antitrust approval for E-Trade acquisition, Bloomberg says » 18:54
03/27/20
03/27
18:54
03/27/20
18:54
MS

Morgan Stanley

$34.01 /

-1.67 (-4.68%)

, ETFC

E-Trade

$34.00 /

-1.77 (-4.95%)

Morgan Stanley (MS) won…

Morgan Stanley (MS) won U.S. antitrust approval for its $13B acquisition of E*Trade (ETFC), Bloomberg's David McLaughlin reports, citing a person familiar with the matter. The Justice Department's antitrust division has signed off on the takeover without requiring any changes, said the person, who asked not to be identified because the decision hasn't been made public. A Morgan Stanley spokesman declined to comment, the report added. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
AG Mortgage disputes RBC's notices of events of default » 18:48
03/27/20
03/27
18:48
03/27/20
18:48
MITT

AG Mortgage

$4.02 /

-0.06 (-1.47%)

, RY

Royal Bank of Canada

$58.75 /

-2.72 (-4.42%)

On March 24, the company…

On March 24, the company received written notices from certain affiliates of Royal Bank of Canada alleging that events of default had occurred with respect to various financing agreements. The company disputes RBC's notices of events of default and filed a suit in federal district court in New York describing the wrongful conduct by RBC and seeking both to enjoin RBC from selling the company's collateral securities as well as damages. The company has also received notifications from several additional financing counterparties of alleged events of default under their financing agreements, and of certain of those counterparties' intentions to accelerate the company's and such subsidiaries' performance obligations under the relevant agreements. Under the terms of the applicable financing arrangements, if the company fails to deliver additional collateral or otherwise meet margin calls when due, the financing counterparties may demand immediate payment by the company of the aggregate outstanding financing obligations owed to such counterparties, and if such financing obligations are not paid, may sell the securities and apply the proceeds to the company's financing obligations and/or take ownership of the securities securing the company's financing obligations. The company may also be liable for a shortfall if the proceeds from such sale or value of such securities is less than the relevant financing obligation.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
AG Mortgage continues discussions with counterparties on forbearance agreements » 18:44
03/27/20
03/27
18:44
03/27/20
18:44
MITT

AG Mortgage

$4.02 /

-0.06 (-1.47%)

Since March 23, the…

Since March 23, the company and several of its subsidiaries have received notifications from several financing counterparties of alleged events of default under their financing agreements, and of certain of those counterparties' intentions to accelerate the company's and such subsidiaries' performance obligations under the relevant agreements. The company and its subsidiaries have disputed certain of those notices. However, in the event of a default under one or more of those agreements, financial and other obligations under such agreements, and in some cases the company's obligations as a guarantor, may be accelerated and the counterparties may take ownership of the securities pledged to secure the financing obligations by the company or its subsidiaries. Certain counterparties have informed the company that they have sold the securities pledged to secure the financing obligations. The company and its subsidiaries also may be subject to penalties under those agreements and may suffer cross-default claims from its other lenders. The company continues to engage in discussions with its financing counterparties with regard to entering into forbearance agreements pursuant to which each counterparty would agree to forbear from exercising its rights and remedies with respect to an event of default under the applicable financing arrangement for an agreed-upon period. The company cannot predict whether its financing counterparties will enter into a forbearance agreement, the timing of any such agreement, or the terms thereof.

Hot Stocks
AG Mortgage suspends dividends » 18:41
03/27/20
03/27
18:41
03/27/20
18:41
MITT

AG Mortgage

$4.02 /

-0.06 (-1.47%)

On March 27, the company…

On March 27, the company announced that the Board has approved a suspension of the company's quarterly dividends on the company's common stock, the company's 8.25% Series A Cumulative Redeemable Preferred Stock, the company's 8.00% Series B Cumulative Redeemable Preferred Stock, and the company's 8.000% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, beginning with the common dividends that normally would have been declared in March and the preferred dividends that would have been declared in May. The Board's decision reflects the company's continuing focus on conserving capital and improving its liquidity position during the current market volatility.

Hot Stocks
JetBlue 'applauds' Trump Administration, Congress for passing CARES Act » 18:39
03/27/20
03/27
18:39
03/27/20
18:39
JBLU

JetBlue

$9.76 /

-1.16 (-10.62%)

JetBlue CEO Robin Hayes…

JetBlue CEO Robin Hayes issued the following statement: "JetBlue applauds President Trump, his Administration and the bipartisan leadership in Congress for coming together to swiftly pass and enact the CARES Act, a bill critical to the future of not just of our aviation industry but our entire country. This historic legislation is an important step for those affected by this unprecedented pandemic. Airlines will continue to provide critical air service throughout this crisis, and we stand ready to support the economic recovery when the crisis is over."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Owens & Minor CEO: We have been ramping PPE production since January » 18:38
03/27/20
03/27
18:38
03/27/20
18:38
OMI

Owens & Minor

$5.51 /

-0.035 (-0.63%)

In an interview on…

In an interview on CNBC's Mad Money, Owens & Minor CEO Edward Pesicka said the company has been running facilities 24/7 to produce masks and other protective equipment. He noted that global demand has increased "exponentially," and the company is working with FEMA and the White House. "We've drastically improved our customer service over the past year," Pesicka added.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Stage Stores to temporarily close all stores, furlough employees » 18:36
03/27/20
03/27
18:36
03/27/20
18:36
SSI

Stage Stores

$0.40 /

-0.0392 (-8.86%)

Stage Stores announced a…

Stage Stores announced a series of steps the company is taking to reduce costs and preserve liquidity in response to increasingly challenging market conditions and the impact of the COVID-19 pandemic. These steps include: Temporarily closing all 738 of its stores at 6 p.m. local time on March 27. Prior to the closings, the company had approximately 393 stores closed in compliance with state and local regulations. The company's stores closing are primarily located in smaller markets and have been operating with reduced hours; Furloughing virtually all the company's associates in stores, field support roles and at the distribution centers. In addition, 87% of the employees at its Houston Support Center are being furloughed, effective March 29. All furloughs will continue until further notice. The company has identified 80 key associates who perform essential functions who are not subject to furlough at this time. While the company will not pay wages to furloughed associates, it will continue the eligible furloughed associate's health and welfare benefits; Reducing pay by at least 25% for the members of the executive leadership team. Members of the company's Board of Directors will not receive compensation during this period. All reductions in pay are effective March 29, and will remain in effect for a period to be determined; and The company will continue to both explore additional opportunities to reduce costs in the near term and evaluate additional measures to preserve liquidity.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Abeona Therapeutics says current clinical trial sites remain open » 18:25
03/27/20
03/27
18:25
03/27/20
18:25
ABEO

Abeona Therapeutics

$2.07 /

-0.015 (-0.72%)

The company said,…

The company said, "We remain committed to advancing our clinical programs, but recognize delays are inevitable in these uncertain times, especially as healthcare resources are justly redirected to those who need them most. We are continually assessing the dynamic situation and implementing plans to minimize disruption. We are also constantly reviewing these plans and associated processes and policies to ensure our patients and employees are safe, and continuity in our scaled back operations remains. While the full impact on our clinical programs cannot be quantified at this point, what we do know is that all current clinical trial sites remain active. We can say with certainty that some sites have paused screening and delays are expected as the situation evolves globally. What we won't know for the foreseeable future is the long-term impact. However, we remain dedicated to communicating frequently and openly with our stakeholders as more information becomes available, including updates on material changes to prior guidance as we continue to follow applicable government, regulatory and institutional guidelines."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Supreme Court of Texas rejects Steak 'n Shake bid to dismiss employee lawsuit » 18:24
03/27/20
03/27
18:24
03/27/20
18:24
BH

Biglari

$50.27 /

-3.51 (-6.53%)

For the second time, the…

For the second time, the Supreme Court of Texas has rejected an attempt by Steak 'n Shake to dismiss a lawsuit filed by a former employee who was allegedly sexually assaulted by her manager. The ruling marks an important victory in efforts to hold businesses accountable for the actions of supervisors, said trial lawyer Matthew McCarley of Dallas-based Fears Nachawati, who represents the plaintiff. With this action, McCarley said he is confident that Steak 'n Shake will have to answer to the claims in a jury trial.

ShowHide Related Items >><<

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.